Abstract
Esophageal squamous cell carcinoma (ESCC) is one of the most serious life-threatening malignancies. Although chemotherapeutic targets and agents for ESCC have made much progress recently, the efficacy is still unsatisfactory. Therefore, there is still an unmet medical need for patients with ESCC. Here, we report the expression status of HDAC1 in human ESCC and matched paracancerous tissues, and the results indicated that HDAC1 was generally upregulated in ESCC specimens. Furthermore, we comprehensively assessed the anti-ESCC activity of a highly active HDAC1 inhibitor quisinostat. Quisinostat could effectively suppress cellular viability and proliferation of ESCC cells, as well as induce cell cycle arrest and apoptosis even at low treatment concentrations. The effectiveness was also observed in KYSE150 xenograft model when quisinostat was administered at tolerated doses (3 mg/kg and 10 mg/kg). Meanwhile, quisinostat also had the ability to suppress the migration and invasion (pivotal steps of tumor metastasis) of ESCC cells. Western blot analysis indicated that quisinostat exerted its anti-ESCC effects mainly through blockade of Akt/mTOR and MAPK/ERK signaling cascades. Overall, HDAC1 may serve as a potential therapeutic target...Continue Reading
References
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janine ArtsPatrick Angibaud
Nov 13, 2012·Molecular Oncology·Maria NewNicholas B La Thangue
May 1, 2013·BMC Cancer·Berit Maria MüllerCarsten Denkert
May 3, 2014·International Journal of Cancer. Journal International Du Cancer·Lei ZhongSheng-Yong Yang
Aug 6, 2014·Proteomics. Clinical Applications·Lorenzo ColarossiClaudius Mueller
Oct 17, 2014·Gut·Melina ArnoldDavid Forman
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jun 21, 2015·Investigational New Drugs·Matthew ZibelmanElizabeth R Plimack
Aug 20, 2015·PloS One·Peng ZhangXiaofeng Zhu
Feb 13, 2016·Chonnam Medical Journal·Somy Yoon, Gwang Hyeon Eom
Mar 24, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kristy WahaibPatrick D Ford
Oct 5, 2016·Journal of Cancer·Min SongBo Zhang
Oct 22, 2016·Pharmacogenomics·Andrew Kl GoeyWilliam D Figg
Dec 31, 2016·Expert Opinion on Therapeutic Patents·Hai-Tao QinFeng Liu
Apr 21, 2017·Oncotarget·Lin-Lin CaoMei Jia
Jun 4, 2017·Surgical Oncology Clinics of North America·Talha ShaikhEric M Horwitz
Jul 4, 2017·International Journal of Molecular Sciences·Tomas EckschlagerJan Hrabeta
Dec 2, 2017·Oncotarget·Fang-Teng LiuZheng-Ming Zhu
Mar 15, 2018·The International Journal of Biochemistry & Cell Biology·Mariarosaria ConteLucia Altucci
Apr 19, 2018·Annals of Translational Medicine·Po-Kuei Hsu
Jun 5, 2018·Trends in Cancer·Carolina Vicente-DueñasIsidro Sánchez-García
Citations
May 24, 2019·Journal of Cellular Physiology·Shanshan MaFangxia Guan
Jun 17, 2020·Experimental and Therapeutic Medicine·Huiwu LiLing Liu
Jul 2, 2019·Molecular Medicine Reports·Xiangdong BaiQiang He
Dec 9, 2020·Toxicology and Applied Pharmacology·Xinhuan WangDongyang Xu
Apr 30, 2021·Investigational New Drugs·Jiong Lin
Apr 26, 2021·Drug Discovery Today·Ganji Purnachandra NagarajuSarfraz Ahmad